GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Clinical trials for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS explained in plain language.
Never miss a new study
Get alerted when new GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS trials appear
Sign up with your email to follow new studies for GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a diabetes drug help teen Girls' periods?
Disease control ENROLLING_BY_INVITATIONThis study is looking at whether adding a GLP-1 drug (dulaglutide) to standard insulin therapy can help regulate menstrual cycles in teenage girls with Type 1 diabetes. It will involve 50 girls aged 12-18 who have poorly controlled diabetes and irregular periods. The goal is to s…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Phase: PHASE1, PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Apr 04, 2026 05:05 UTC
-
Popular weight loss drugs may require longer Pre-Surgery fasting, new study investigates
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand how GLP-1 receptor agonist drugs (used for weight loss and diabetes) slow stomach emptying in people scheduled for surgery. Researchers will measure stomach contents in 100 patients taking these drugs to determine how long they should fast before ane…
Matched conditions: GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS
Sponsor: Wael Saasouh, MD • Aim: Knowledge-focused
Last updated Apr 04, 2026 05:05 UTC